Press-release for stocks related to pharma for alpmy

| -4.86% | O: 0.41% H: 0.0% C: 0.0%
CSLLY | $89.17 3.3% 54K

| -3.75% | O: -4.92% H: 3.76% C: 3.44%
GLAXF | News | $20.305 -14.18% 630

| -8.99% | O: -3.4% H: 1.49% C: 1.49%
AZNCF | News | $138.73 -4.19% 3.7K

| 7.0% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | News | $9.53 -1.11% 690K

| -10.64% | O: -1.41% H: 5.06% C: 4.01%
GSK | News | $41.24 1.6% 0.0% 2.3M

| -4.4% | O: -0.6% H: 0.19% C: 0.09%
ABT | News | $107.59 0.49% -0.09% 3.8M

| -10.93% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M

| 6.54% | O: 1.08% H: 0.82% C: 0.67%
pharma vaccine astrazeneca research key market

Vivtex Enters Research Collaboration with Astellas Pharma
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
ALPMF | News | $9.75 43.47% 200

| -21.08% | O: 0.27% H: 0.0% C: 0.0%
ALPMY | News | $9.53 -1.11% 690K

| -17.98% | O: -0.11% H: 0.37% C: -0.15%
pharma research collaboration

Outcome Capital Announces Acquisition of Propella Therapeutics, Portfolio Company of Peterson Companies, by Astellas Pharma
Published: 2024-01-04 (Crawled : 23:00) - biospace.com/
ALPMF | News | $9.75 43.47% 200

| -20.52% | O: -0.02% H: 2.93% C: 2.93%
ALPMY | News | $9.53 -1.11% 690K

| -19.3% | O: 2.89% H: 0.58% C: -0.33%
pharma company acquisition

Pompe Disease Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Leading Companies - Asklepios Biopharmaceutical, Inc., Astellas Pharma Inc., Amicus Therapeutics, Sanofi, Spark Therapeutics
Published: 2023-10-26 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -10.45% | O: -18.18% H: 0.0% C: 0.0%
ALPMY | News | $9.53 -1.11% 690K

| -25.16% | O: 4.02% H: 0.0% C: -4.32%
SRPT | $117.065 0.09% 0.09% 440K

| 4.95% | O: 0.27% H: 0.0% C: -4.53%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -11.44% | O: -15.73% H: 0.0% C: 0.0%
pharma disease companies therapeutics growth market

Oncology Drugs Market to grow at a CAGR of 11.99% from 2022 to 2027. AbbVie Inc., Amgen Inc. & Apikos Pharma are major vendors - Technavio
Published: 2023-07-27 (Crawled : 05:00) - prnewswire.com
ABBNY | News | $48.5 4.05% 200K

| 21.71% | O: 2.13% H: 0.04% C: -1.67%
ABLZF | News | $50.158 -32.74% 1.9K

Producer Manufacturing

| 18.77% | O: 0.58% H: 0.0% C: -0.46%
GLAXF | News | $20.305 -14.18% 630

| 8.37% | O: 2.38% H: 2.49% C: 2.49%
ALPMY | News | $9.53 -1.11% 690K

| -36.39% | O: 3.75% H: 0.0% C: -2.78%
NVS | News | $97.28 2.27% 0.31% 3.7M

| -4.84% | O: 0.7% H: 0.12% C: -0.76%
GSK | News | $41.24 1.6% 0.0% 2.3M

| 14.97% | O: 1.03% H: 0.39% C: -1.02%
ABBV | News | $169.54 0.98% -0.91% 4.1M

| 19.85% | O: 2.13% H: 4.77% C: 3.02%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -11.31% | O: 0.92% H: 0.0% C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M

| 16.3% | O: -0.31% H: 1.71% C: 0.67%
pharma abbvie market

Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 11:00) - prnewswire.com
CSLLY | $89.17 3.3% 54K

| -0.2% | O: -0.54% H: 0.0% C: -1.4%
GLAXF | News | $20.305 -14.18% 630

| 10.71% | O: 0.0% H: 1.42% C: 0.96%
AZNCF | News | $138.73 -4.19% 3.7K

| 5.01% | O: 6.03% H: -2.14% C: -2.14%
ALPMY | News | $9.53 -1.11% 690K

| -34.6% | O: 0.96% H: 0.0% C: -1.71%
GSK | News | $41.24 1.6% 0.0% 2.3M

| 18.51% | O: 0.03% H: 0.2% C: -0.8%
ABT | News | $107.59 0.49% -0.09% 3.8M

| -0.14% | O: 0.24% H: 0.44% C: -0.06%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -10.4% | O: 0.36% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M

| 4.64% | O: 1.79% H: 0.0% C: -2.23%
pharma vaccine research market

Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026; Astellas Pharma Inc., Athersys Inc., among others, emerge as key vendors - Technavio
Published: 2023-04-12 (Crawled : 14:20) - prnewswire.com
NVSEF | News | $95.11 6.88% 490

| 20.94% | O: 1.1% H: 0.0% C: 0.0%
ALPMY | News | $9.53 -1.11% 690K

| -32.46% | O: 1.92% H: 0.77% C: 0.56%
NVS | News | $97.28 2.27% 0.31% 3.7M

| 3.19% | O: 0.75% H: 0.5% C: -0.05%
BCLI A | $0.531 -1.69% -1.71% 170K

| -81.47% | O: -2.1% H: 0.36% C: -6.07%
pharma cell therapy market

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

| -94.35% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $89.17 3.3% 54K

| -7.0% | O: -3.93% H: 2.17% C: 1.75%
MNK | $0.3402 -0.06% 540K

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | News | $20.305 -14.18% 630

| 11.75% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | News | $92.7 -2.18% 600K

| -2.1% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $64.93 -4.38% 6.2K

| 66.06% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | News | $9.53 -1.11% 690K

| -37.4% | O: 3.43% H: 0.0% C: -2.93%
VTRS | News A | $11.36 0.98% 0.97% 4.7M

| 2.07% | O: 0.54% H: 2.5% C: 1.7%
NVO | News | $128.64 2.7% -0.07% 3.7M

| -4.95% | O: 1.43% H: 0.84% C: -0.23%
NVS | News | $97.28 2.27% 0.31% 3.7M

| 8.97% | O: 0.42% H: 1.35% C: 1.22%
JNJ | News | $149.56 0.3% 0.0% 9.1M

| -15.28% | O: -0.28% H: 1.26% C: 1.15%
GSK | News | $41.24 1.6% 0.0% 2.3M

| 17.36% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.53 0.95% 0.0% 4M

| 35.83% | O: 0.48% H: 3.96% C: -0.48%
ABBV | News | $169.54 0.98% -0.91% 4.1M

| 4.91% | O: 0.27% H: 0.6% C: 0.21%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -2.69% | O: 0.16% H: 0.0% C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M

| 4.15% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development
Published: 2022-06-27 (Crawled : 23:00) - biospace.com/
ALPMY | News | $9.53 -1.11% 690K

| -41.44% | O: -1.2% H: 0.0% C: -0.37%
EPIX | $6.475 1.17% 1.16% 130K

| 60.0% | O: 2.25% H: 0.0% C: -2.69%
epi-7386 pharma therapy update

Interstitial Cystitis Drugs Market - 36% of Growth to Originate from North America| Evolving Opportunities with Astellas Pharma Inc. & Bayer AG | 17000+ Technavio Reports
Published: 2022-06-01 (Crawled : 07:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490

| 27.72% | O: -0.67% H: 0.0% C: 0.0%
ALPMY | News | $9.53 -1.11% 690K

| -40.35% | O: 1.7% H: 0.37% C: -0.31%
VTRS | News A | $11.36 0.98% 0.97% 4.7M

| -6.73% | O: 1.23% H: 0.36% C: -2.11%
NVS | News | $97.28 2.27% 0.31% 3.7M

| 9.26% | O: -0.13% H: 0.0% C: 0.0%
pharma growth market

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2022
Published: 2022-05-10 (Crawled : 12:20) - biospace.com/
ALPMY | News | $9.53 -1.11% 690K

| -34.73% | O: 3.06% H: 0.03% C: -0.47%
EPIX | $6.475 1.17% 1.16% 130K

| 16.36% | O: 3.09% H: 8.47% C: 6.35%
pharma

Vaccines Market Potential to Grow by USD 28.28 billion | Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd. Emerge as Dominant Players | Technavio
Published: 2022-05-02 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -10.45% | O: 0.08% H: 0.0% C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K

| 6.02% | O: -1.7% H: 0.0% C: -0.06%
ALPMY | News | $9.53 -1.11% 690K

| -37.44% | O: -1.05% H: 0.2% C: -0.27%
GSK | News | $41.24 1.6% 0.0% 2.3M

| -9.5% | O: -0.92% H: 0.29% C: -0.95%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -12.66% | O: -2.05% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M

| 6.7% | O: -0.35% H: 0.0% C: 0.0%
pharma biotech potential market

Astellas Pharma Canada Named by the Canadian Society of Transplantation as Member of the Living Donor Circle of Excellence Program
Published: 2021-09-15 (Crawled : 17:00) - biospace.com/
ALPMF | News | $9.75 43.47% 200

| Email alert Add to watchlist
ALPMY | News | $9.53 -1.11% 690K

| Email alert Add to watchlist
pharma

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

Finance

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M

Finance

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M